中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/01/29 | 6,290 | 6,400 | 6,250 | 6,380 | +110 | +1.8% | 844,700 |
2019/01/28 | 6,270 | 6,340 | 6,180 | 6,270 | -60 | -0.9% | 868,700 |
2019/01/25 | 6,360 | 6,420 | 6,330 | 6,330 | -190 | -2.9% | 1,075,000 |
2019/01/24 | 6,510 | 6,530 | 6,460 | 6,520 | ±0 | ±0% | 453,100 |
2019/01/23 | 6,500 | 6,550 | 6,440 | 6,520 | -40 | -0.6% | 624,900 |
2019/01/22 | 6,670 | 6,670 | 6,480 | 6,560 | -60 | -0.9% | 785,800 |
2019/01/21 | 6,760 | 6,760 | 6,570 | 6,620 | -60 | -0.9% | 592,500 |
2019/01/18 | 6,590 | 6,740 | 6,570 | 6,680 | +130 | +2% | 660,800 |
2019/01/17 | 6,590 | 6,630 | 6,530 | 6,550 | +10 | +0.2% | 732,400 |
2019/01/16 | 6,580 | 6,610 | 6,510 | 6,540 | ±0 | ±0% | 737,300 |
2019/01/15 | 6,420 | 6,580 | 6,400 | 6,540 | +80 | +1.2% | 1,032,500 |
2019/01/11 | 6,520 | 6,630 | 6,390 | 6,460 | -90 | -1.4% | 1,221,300 |
2019/01/10 | 6,590 | 6,660 | 6,520 | 6,550 | -80 | -1.2% | 764,200 |
2019/01/09 | 6,460 | 6,730 | 6,450 | 6,630 | +190 | +3% | 963,700 |
2019/01/08 | 6,540 | 6,540 | 6,410 | 6,440 | -50 | -0.8% | 960,500 |
2019/01/07 | 6,520 | 6,590 | 6,460 | 6,490 | +170 | +2.7% | 1,076,900 |
2019/01/04 | 6,180 | 6,350 | 6,170 | 6,320 | -60 | -0.9% | 1,571,500 |
2018/12/28 | 6,490 | 6,510 | 6,340 | 6,380 | -170 | -2.6% | 922,700 |
2018/12/27 | 6,480 | 6,610 | 6,430 | 6,550 | +170 | +2.7% | 1,315,700 |
2018/12/26 | 6,320 | 6,420 | 6,270 | 6,380 | +100 | +1.6% | 1,025,500 |
2018/12/25 | 6,460 | 6,470 | 6,230 | 6,280 | -340 | -5.1% | 1,137,100 |
2018/12/21 | 6,830 | 6,860 | 6,620 | 6,620 | -240 | -3.5% | 1,445,000 |
2018/12/20 | 7,000 | 7,060 | 6,820 | 6,860 | -240 | -3.4% | 1,218,700 |
2018/12/19 | 7,180 | 7,180 | 7,060 | 7,100 | -40 | -0.6% | 715,100 |
2018/12/18 | 7,200 | 7,230 | 7,080 | 7,140 | -140 | -1.9% | 827,800 |
2018/12/17 | 7,330 | 7,370 | 7,260 | 7,280 | +40 | +0.6% | 735,900 |
2018/12/14 | 7,330 | 7,370 | 7,190 | 7,240 | -100 | -1.4% | 1,713,600 |
2018/12/13 | 7,360 | 7,400 | 7,290 | 7,340 | ±0 | ±0% | 836,700 |
2018/12/12 | 7,260 | 7,410 | 7,260 | 7,340 | +170 | +2.4% | 1,109,900 |
2018/12/11 | 7,200 | 7,260 | 7,150 | 7,170 | -30 | -0.4% | 809,400 |
2018/12/10 | 7,150 | 7,220 | 7,140 | 7,200 | -100 | -1.4% | 751,500 |
2018/12/07 | 7,300 | 7,370 | 7,230 | 7,300 | +50 | +0.7% | 817,400 |
2018/12/06 | 7,300 | 7,360 | 7,170 | 7,250 | -150 | -2% | 1,073,700 |
2018/12/05 | 7,440 | 7,450 | 7,330 | 7,400 | -110 | -1.5% | 972,100 |
2018/12/04 | 7,640 | 7,650 | 7,490 | 7,510 | -110 | -1.4% | 1,041,100 |
2018/12/03 | 7,810 | 7,850 | 7,580 | 7,620 | -150 | -1.9% | 1,244,900 |
2018/11/30 | 7,700 | 7,780 | 7,590 | 7,770 | +160 | +2.1% | 1,528,100 |
2018/11/29 | 7,520 | 7,700 | 7,500 | 7,610 | +130 | +1.7% | 763,700 |
2018/11/28 | 7,260 | 7,560 | 7,240 | 7,480 | +250 | +3.5% | 1,187,700 |
2018/11/27 | 7,270 | 7,280 | 7,160 | 7,230 | +20 | +0.3% | 652,800 |
2018/11/26 | 7,250 | 7,300 | 7,120 | 7,210 | -50 | -0.7% | 832,300 |
2018/11/22 | 7,120 | 7,300 | 7,120 | 7,260 | +170 | +2.4% | 752,900 |
2018/11/21 | 7,000 | 7,120 | 6,970 | 7,090 | -40 | -0.6% | 794,400 |
2018/11/20 | 7,150 | 7,190 | 7,100 | 7,130 | -20 | -0.3% | 586,000 |
2018/11/19 | 7,090 | 7,190 | 7,080 | 7,150 | +70 | +1% | 605,700 |
2018/11/16 | 7,000 | 7,150 | 6,960 | 7,080 | +180 | +2.6% | 817,700 |
2018/11/15 | 6,790 | 6,940 | 6,780 | 6,900 | +20 | +0.3% | 454,000 |
2018/11/14 | 6,940 | 6,990 | 6,840 | 6,880 | +10 | +0.1% | 661,100 |
2018/11/13 | 6,840 | 6,880 | 6,730 | 6,870 | -20 | -0.3% | 777,100 |
2018/11/12 | 6,850 | 6,950 | 6,800 | 6,890 | +30 | +0.4% | 434,000 |
1551~
1600
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 775,400円 | +1.7% | +5.0% | 3.22% | 31.12倍 | 6.71倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 434,900円 | -1.1% | +75.3% | 4.60% | 29.79倍 | 0.98倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 352,900円 | +6.0% | +4.0% | 2.21% | 21.91倍 | 4.05倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 730,900円 | +2.2% | +10.2% | 1.64% | 14.04倍 | 1.41倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 141,100円 | +0.9% | +380.2% | 5.53% | 19.44倍 | 1.67倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム